Literature DB >> 24632622

Lysyl oxidase-like 2 (LOXL2) and E47 EMT factor: novel partners in E-cadherin repression and early metastasis colonization.

G Canesin1, E P Cuevas1, V Santos1, C López-Menéndez1, G Moreno-Bueno2, Y Huang3, K Csiszar4, F Portillo1, H Peinado3, D Lyden3, A Cano1.   

Abstract

Epithelial-mesenchymal transition (EMT) has been associated with increased aggressiveness and acquisition of migratory properties providing tumor cells with the ability to invade into adjacent tissues. Downregulation of E-cadherin, a hallmark of EMT, is mediated by several transcription factors (EMT-TFs) that act also as EMT inducers, among them, Snail1 and the bHLH transcription factor E47. We previously described lysyl oxidase-like 2 (LOXL2), a member of the lysyl oxidase family, as a Snail1 regulator and EMT inducer. Here we show that LOXL2 is also an E47-interacting partner and functionally collaborates in the repression of E-cadherin promoter. Loss and gain of function analyses combined with in vivo studies in syngeneic breast cancer models demonstrate the participation of LOXL2 and E47 in tumor growth and their requirement for lung metastasis. Furthermore, LOXL2 and E47 contribute to early steps of metastatic colonization by cell and noncell autonomous functions regulating the recruitment of bone marrow progenitor cells to the lungs and by direct transcriptional regulation of fibronectin and cytokines TNFα, ANG-1 and GM-CSF. Moreover, fibronectin and GM-CSF proved to be necessary for LOXL2/E47-mediated modulation of tumor growth and lung metastasis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24632622     DOI: 10.1038/onc.2014.23

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  43 in total

1.  Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice.

Authors:  Joni M Mäki; Juha Räsänen; Hilkka Tikkanen; Raija Sormunen; Kaarin Mäkikallio; Kari I Kivirikko; Raija Soininen
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

2.  Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

Authors:  Oscar H Ocaña; Rebeca Córcoles; Angels Fabra; Gema Moreno-Bueno; Hervé Acloque; Sonia Vega; Alejandro Barrallo-Gimeno; Amparo Cano; M Angela Nieto
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

3.  A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions.

Authors:  M A Perez-Moreno; A Locascio; I Rodrigo; G Dhondt; F Portillo; M A Nieto; A Cano
Journal:  J Biol Chem       Date:  2001-04-17       Impact factor: 5.157

4.  A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression.

Authors:  Héctor Peinado; Maria Del Carmen Iglesias-de la Cruz; David Olmeda; Katalin Csiszar; Keith S K Fong; Sonia Vega; Maria Angela Nieto; Amparo Cano; Francisco Portillo
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

Review 5.  The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity.

Authors:  M Angela Nieto; Amparo Cano
Journal:  Semin Cancer Biol       Date:  2012-05-18       Impact factor: 15.707

6.  LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis.

Authors:  Thomas R Cox; Demelza Bird; Ann-Marie Baker; Holly E Barker; Melisa W-Y Ho; Georgina Lang; Janine T Erler
Journal:  Cancer Res       Date:  2013-01-23       Impact factor: 12.701

7.  The AD1 transactivation domain of E2A contains a highly conserved helix which is required for its activity in both Saccharomyces cerevisiae and mammalian cells.

Authors:  M E Massari; P A Jennings; C Murre
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

Review 8.  The rationale for targeting the LOX family in cancer.

Authors:  Holly E Barker; Thomas R Cox; Janine T Erler
Journal:  Nat Rev Cancer       Date:  2012-07-19       Impact factor: 60.716

9.  LOXL2-mediated matrix remodeling in metastasis and mammary gland involution.

Authors:  Holly E Barker; Joan Chang; Thomas R Cox; Georgina Lang; Demelza Bird; Monica Nicolau; Holly R Evans; Alison Gartland; Janine T Erler
Journal:  Cancer Res       Date:  2011-01-13       Impact factor: 12.701

10.  LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition.

Authors:  Eva P Cuevas; Gema Moreno-Bueno; Giacomo Canesin; Vanesa Santos; Francisco Portillo; Amparo Cano
Journal:  Biol Open       Date:  2014-02-15       Impact factor: 2.422

View more
  45 in total

1.  Evaluation of transforming growth factor-β1 suppress Pokemon/epithelial-mesenchymal transition expression in human bladder cancer cells.

Authors:  Wei Li; Amritha Kidiyoor; Yangyang Hu; Changcheng Guo; Min Liu; Xudong Yao; Yuanyuan Zhang; Bo Peng; Junhua Zheng
Journal:  Tumour Biol       Date:  2014-10-22

2.  Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer.

Authors:  Fernando Salvador; Alberto Martin; Celia López-Menéndez; Gema Moreno-Bueno; Vanesa Santos; Alberto Vázquez-Naharro; Patricia G Santamaria; Saleta Morales; Pierre R Dubus; Laura Muinelo-Romay; Rafael López-López; Jason C Tung; Valerie M Weaver; Francisco Portillo; Amparo Cano
Journal:  Cancer Res       Date:  2017-07-18       Impact factor: 12.701

Review 3.  Tumour-adipose tissue crosstalk: fuelling tumour metastasis by extracellular vesicles.

Authors:  Lucía Robado de Lope; Olwen Leaman Alcíbar; Ana Amor López; Marta Hergueta-Redondo; Héctor Peinado
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-05       Impact factor: 6.237

4.  Expression of poly(C)-binding protein 1 (PCBP1) in NSCLC as a negative regulator of EMT and its clinical value.

Authors:  Yifei Liu; Ling Gai; Jian Liu; Yuan Cui; Yan Zhang; Jia Feng
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 5.  Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications.

Authors:  Andrew R Chin; Shizhen Emily Wang
Journal:  Clin Cancer Res       Date:  2016-06-01       Impact factor: 12.531

Review 6.  Targeting metastasis.

Authors:  Patricia S Steeg
Journal:  Nat Rev Cancer       Date:  2016-04       Impact factor: 60.716

Review 7.  Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer.

Authors:  Philip C Trackman
Journal:  Expert Opin Ther Targets       Date:  2016-03-03       Impact factor: 6.902

8.  Grhl3 induces human epithelial tumor cell migration and invasion via downregulation of E-cadherin.

Authors:  Pan Zhao; Sijia Guo; Zhenzhen Tu; Lijun Di; Xiaojun Zha; Haisheng Zhou; Xuejun Zhang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-01       Impact factor: 3.848

9.  Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression.

Authors:  Alberto Martin; Fernando Salvador; Gema Moreno-Bueno; Alfredo Floristán; Cristina Ruiz-Herguido; Eva P Cuevas; Saleta Morales; Vanesa Santos; Katalin Csiszar; Pierre Dubus; Jody J Haigh; Anna Bigas; Francisco Portillo; Amparo Cano
Journal:  EMBO J       Date:  2015-03-10       Impact factor: 11.598

10.  E2A Modulates Stemness, Metastasis, and Therapeutic Resistance of Breast Cancer.

Authors:  Celia López-Menéndez; Alberto Vázquez-Naharro; Vanesa Santos; Pierre Dubus; Patricia G Santamaría; Ángel Martínez-Ramírez; Francisco Portillo; Gema Moreno-Bueno; Marisa M Faraldo; Amparo Cano
Journal:  Cancer Res       Date:  2021-06-18       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.